Servier, SIMM Set to Collaborate on Targeted Drug for Breast Cancer
By Shannon Ellis
Thursday, October 3, 2013
SHANGHAI – A well-established French biotech company is working with one of China’s most authoritative state drug discovery organizations to develop a drug that could help the country tackle the growing incidence of breast cancer.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.